We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

OPERA Database - Crohn's Protocol (OPERA)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01720368
First Posted: November 2, 2012
Last Update Posted: August 17, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Abbott
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center
  Purpose
The investigators believe that patients with Crohn's disease are able to report details of their own medical history accurately and record changes in clinical status effectively over time. Using an internet-based database the investigators will ask patients to report their own disease history, and the investigators will compare their reports to the medical record.

Condition
Inflammatory Bowel Disease Crohn's Disease

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: IBD-OPERA Database IBD OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database - Crohn's Protocol

Resource links provided by NLM:


Further study details as provided by Dartmouth-Hitchcock Medical Center:

Primary Outcome Measures:
  • Validity of patient self reporting [ Time Frame: 12 months ]
    The validity of patient self report on details of their Crohn's disease compared to chart review. Validity is defined as a match between patient self report and medical records.


Enrollment: 50
Study Start Date: October 2012
Study Completion Date: June 2015
Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
1st Group of 50 patients
2nd Group of 50 patients

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Men and women over 18 years of age with Crohn's disease
Criteria

Inclusion Criteria:

  • Adults (over 18 years of age) with physician diagnosed Crohn's disease
  • A current or past prescription of anti-TNF
  • Access to medical record for validation of clinical information

Exclusion Criteria:

  • Unwilling or unable to provide informed consent for study participation
  • Unable to access or use the internet
  • Ulcerative colitis or IBD-U
  • Illiterate or does not possess minimum level of literacy required to complete questionnaire
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01720368


Locations
United States, New Hampshire
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
Sponsors and Collaborators
Dartmouth-Hitchcock Medical Center
Abbott
  More Information

Responsible Party: Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier: NCT01720368     History of Changes
Other Study ID Numbers: IMM 10-0162
First Submitted: October 31, 2012
First Posted: November 2, 2012
Last Update Posted: August 17, 2015
Last Verified: August 2015

Keywords provided by Dartmouth-Hitchcock Medical Center:
IBD
Crohn's

Additional relevant MeSH terms:
Crohn Disease
Intestinal Diseases
Inflammatory Bowel Diseases
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases